Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_assertion type Assertion NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_head.
- NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_assertion description "[High expression of CCNE2, but not CCNE1, was characteristic of the luminal B and HER2 subtypes of breast cancer and was strongly predictive of shorter distant metastasis-free survival following endocrine therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_provenance.
- NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_assertion evidence source_evidence_literature NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_provenance.
- NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_assertion SIO_000772 22564725 NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_provenance.
- NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_assertion wasDerivedFrom befree-20140225 NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_provenance.
- NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_assertion wasGeneratedBy ECO_0000203 NP662001.RAsA2o12M1K-3-YUx_EWsIK7niSF4ycqE4ACIGPr--6Hs130_provenance.